Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2493091 | 1.00 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL25292780 | 1.00 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL25290868 | 0.95 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2489714 | 0.95 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL25291631 | 0.95 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2490527 | 0.95 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL25292722 | 0.82 | SELP (0.47) | SELP | |
| SCHEMBL2792360 | 0.82 | SELP (0.47) | SELP | |
| SCHEMBL2793756 | 0.82 | SELP (0.47) | SELP | |
| SCHEMBL25249456 | 0.82 | SELP (0.47) | SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7862804-B2 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | LOREAL (FR) | 2011-01-04 | — | — | US | claimed |
| EP-1774990-B1 | Use of c-glycosides for depigmenting skin | OREAL (FR) | 2009-12-09 | — | — | EP | claimed |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | L'OREAL (FR) | 2007-04-12 | — | — | US | claimed |
| EP-2043594-B1 | COSMETIC USE OF A C-GLYCOSIDE DERIVATIVE IN COMBINATION WITH ASCORBIC ACID | L'ORÉAL (FR) | 2017-03-15 | — | — | EP | disclosed |
| US-9421157-B2 | Use of C-glycoside derivatives as pro-desquamating active agents | L'OREAL (FR) | 2016-08-23 | — | — | US | disclosed |
| WO-2013034855-A2 | COMBINATION OF CARRAGEENAN AND C-GLYCOSIDE AND USES THEREOF | L'OREAL (FR) | 2013-03-14 | — | — | WO | disclosed |
| EP-2379050-A2 | PRODUCT FOR PREVENTING OR TREATING HAIR GREYING | L'Oréal (FR) | 2011-10-26 | — | — | EP | disclosed |
| US-7862804-B2 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | LOREAL (FR) | 2011-01-04 | — | — | US | disclosed |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | L'OREAL (FR) | 2010-07-29 | — | — | US | disclosed |
| WO-2010082001-A2 | PRODUCT FOR PREVENTING OR TREATING HAIR GREYING | L'OREAL (FR) | 2010-07-22 | — | — | WO | disclosed |
| US-20100112100-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | L'OREAL (FR) | 2010-05-06 | — | — | US | disclosed |
| WO-2008004165-A2 | USE OF C-GLYCOSIDE DERIVATIVES AS PRO-DESQUAMATING ACTIVE AGENTS | L'OREAL (FR) | 2008-01-10 | — | — | WO | disclosed |
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | L'OREAL S.A. (FR) | 2008-01-10 | — | — | US | disclosed |
| US-20080008674-A1 | Use of C-glycoside derivative for improving the skin's barrier function | L'OREAL (FR) | 2008-01-10 | — | — | US | disclosed |
| WO-2008004164-A2 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMBINING A C-GLYCOSIDE DERIVATIVE AND A DESQUAMATING AGENT | L'OREAL (FR) | 2008-01-10 | — | — | WO | disclosed |
| EP-1875893-A2 | Composition combining a C-glycoside derivative with an associative polymer | L'OREAL (FR) | 2008-01-09 | — | — | EP | disclosed |
| EP-1875894-A2 | Use of at least one C-glycoside derivative as a soothing agent | L'OREAL (FR) | 2008-01-09 | — | — | EP | disclosed |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | L'OREAL (FR) | 2008-01-03 | — | — | US | disclosed |
| EP-1774990-A1 | Use of c-glycosides for depigmenting skin | L'Oréal (FR) | 2007-04-18 | — | — | EP | disclosed |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | L'OREAL (FR) | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | DSG1, TYR, CUTA | LGALS1 129/4885LGALS3 100/4885LGALS9 469/4885 |
| US-20070081956-A1 | Admistration of C-glycoside compounds for depigmenting/whitening the skin | TYR, CAT, NQO1 | LGALS1 640/4885LGALS3 554/4885LGALS9 1197/4885 |
| US-20100190742-A1 | COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING | GLA, CD44, FUT6 | LGALS1 88/4885LGALS3 81/4885LGALS9 235/4885 |
| US-20100112100-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | UGCG, GANC, CUTA | LGALS1 187/4885LGALS3 146/4885LGALS9 263/4885 |
| US-20080008674-A1 | Use of C-glycoside derivative for improving the skin's barrier function | CUTA, UGCG, GLA | LGALS1 29/4885LGALS3 20/4885LGALS9 35/4885 |
| US-20080003191-A1 | Composition combining a C-glycoside derivative and an emulsifying polymer | CUTA, UGCG, PSAP | LGALS1 154/4885LGALS3 98/4885LGALS9 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.